Overview
Christopher Hourigan is an Oncologist in Baltimore, Maryland. Dr. Hourigan is rated as a Distinguished provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Childhood Acute Myeloid Leukemia, Bone Graft, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 144 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 103 articles and participated in 2 clinical trials in the study of Leukemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Johns Hopkins University
Mark Levis is an Oncologist in Bethesda, Maryland. Dr. Levis is rated as an Elite provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
National Cancer Institute
Steven Gore, MD, earned his undergraduate and doctoral degrees at Yale, performed his residency at the University of Chicago and his oncology fellowship at Johns Hopkins. He rose from instructor to full professor at Johns Hopkins, and, in 2013, he became professor of medicine and director of hematologic malignancies at Yale. Dr. Gore is rated as a Distinguished provider by MediFind in the treatment of Leukemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Tissue Biopsy.
Johns Hopkins University
Amy Dezern is an Oncologist and a Hematologist in Columbia, Maryland. Dr. Dezern is rated as an Elite provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dezern is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Dr. Hourigan isElite. Learn about Acute Myeloid Leukemia (AML).
- Distinguished
- LeukemiaDr. Hourigan isDistinguished. Learn about Leukemia.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Childhood Acute Myeloid LeukemiaDr. Hourigan isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Hourigan isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Hourigan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Hourigan isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Bone GraftDr. Hourigan isExperienced. Learn about Bone Graft.
- Bone Marrow AspirationDr. Hourigan isExperienced. Learn about Bone Marrow Aspiration.
- Chronic Myelogenous Leukemia (CML)Dr. Hourigan isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Familial Wilms Tumor 2Dr. Hourigan isExperienced. Learn about Familial Wilms Tumor 2.